ERGOCALCIFEROL Drug Patent Profile
✉ Email this page to a colleague
When do Ergocalciferol patents expire, and when can generic versions of Ergocalciferol launch?
Ergocalciferol is a drug marketed by Chartwell Rx, Puracap Pharm Llc, Sigmapharm Labs Llc, Strides Pharma, and Sun Pharm Inds Inc. and is included in five NDAs.
The generic ingredient in ERGOCALCIFEROL is ergocalciferol. There are six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ergocalciferol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ergocalciferol
A generic version of ERGOCALCIFEROL was approved as ergocalciferol by CHARTWELL RX on May 20th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERGOCALCIFEROL?
- What are the global sales for ERGOCALCIFEROL?
- What is Average Wholesale Price for ERGOCALCIFEROL?
Summary for ERGOCALCIFEROL
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 18 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 48 |
| Patent Applications: | 3,434 |
| Drug Prices: | Drug price information for ERGOCALCIFEROL |
| Drug Sales Revenues: | Drug sales revenues for ERGOCALCIFEROL |
| DailyMed Link: | ERGOCALCIFEROL at DailyMed |
See drug prices for ERGOCALCIFEROL
Recent Clinical Trials for ERGOCALCIFEROL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| University of North Carolina, Chapel Hill | Phase 2 |
| National Institute on Minority Health and Health Disparities (NIMHD) | Phase 2 |
Pharmacology for ERGOCALCIFEROL
| Drug Class | Provitamin D2 Compound |
Anatomical Therapeutic Chemical (ATC) Classes for ERGOCALCIFEROL
US Patents and Regulatory Information for ERGOCALCIFEROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | ERGOCALCIFEROL | ergocalciferol | CAPSULE;ORAL | 040833-001 | May 20, 2009 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Strides Pharma | ERGOCALCIFEROL | ergocalciferol | CAPSULE;ORAL | 090455-001 | Aug 3, 2010 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Puracap Pharm Llc | ERGOCALCIFEROL | ergocalciferol | CAPSULE;ORAL | 204276-001 | Dec 7, 2018 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
